K181329

Substantially Equivalent

EliA B2-Glycoprotein I IgA Immunoassay, EliA Cardiolipin IgA Immunoassay

Applicant: Phadia AB
Product code: MSV
Advisory panel: Immunology
Date received: 2018-05-18
Decision date: 2018-06-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Uppsala, SE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.